Logo for CANbridge Pharmaceuticals Inc

CANbridge Pharmaceuticals Investor Relations Material

Latest events

Logo for CANbridge Pharmaceuticals Inc

Study Update

CANbridge Pharmaceuticals
Logo for CANbridge Pharmaceuticals

H1 2024

29 Aug, 2024
Logo for CANbridge Pharmaceuticals

H2 2023

28 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from CANbridge Pharmaceuticals Inc

Access all reports
CANbridge Pharmaceuticals Inc is a Chinese biopharmaceutical company focused on developing and commercializing treatments for rare diseases and cancer. The company engages in drug discovery, licensing, and clinical development, with a pipeline spanning gene therapy and biologics. It operates in both China and global markets through partnerships and R&D collaborations. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.